Low levels of heme oxygenase-1 in induced sputum of lung cancer patients as a marker of defective cytoprotection

A. Bar-Shai, A. Ahimor, M. Stark, E. Fireman (Tel-Aviv, Israel)

Source: Annual Congress 2012 - New biomarkers for lung cancer
Session: New biomarkers for lung cancer
Session type: Thematic Poster Session
Number: 4212
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Bar-Shai, A. Ahimor, M. Stark, E. Fireman (Tel-Aviv, Israel). Low levels of heme oxygenase-1 in induced sputum of lung cancer patients as a marker of defective cytoprotection. Eur Respir J 2012; 40: Suppl. 56, 4212

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum haem oxygenase-1 as marker of lung function in patients with chronic silicosis
Source: Annual Congress 2009 - Old and new topics in environmental and occupational lung disease
Year: 2009


Impaired haem oxygenase-1 expression in sputum macrophages of COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 748s
Year: 2006

Inhibition of heme oxygenase-1 enhances chemosensitivity of cisplatin in lung cancer cells
Source: Eur Respir J 2006; 28: Suppl. 50, 336s
Year: 2006

Haem oxygenase-1 expression is diminished in alveolar macrophages of patients with COPD
Source: Eur Respir J 2004; 23: 652-653
Year: 2004


Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients
Source: Eur Respir J 2003; 21: 971-976
Year: 2003



Significant correlation between interleukin-10 expression and progression of non-small cell lung cancer through heme oxygenase
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005

c-Fos overexpression induces resistance to hyperoxia by the upregulation of heme oxygenase-1
Source: Eur Respir J 2004; 24: Suppl. 48, 106s
Year: 2004

Decreased expression of haem oxygenase-1 by alveolar macrophages in idiopathic pulmonary fibrosis
Source: Eur Respir J 2008; 31: 1030-1036
Year: 2008



NADPH oxidase isoform 1 is expressed in lung tissue of ARDS patients and decreases hyperoxia-induced ROS production and cell death in pulmonary type II epithelial cells
Source: Annual Congress 2011 - Barrier functions in sepsis and acute lung injury
Year: 2011


Differential expression of heme oxygenase (HO)-1 in macrophages of lung tumour and tumour-free lung tissues
Source: Annual Congress 2004 - Lung development and cancer
Year: 2004


Increased heme oxygenase-1 and -2 expression in severe COPD exacerbations
Source: Eur Respir J 2003; 22: Suppl. 45, 549s
Year: 2003

Elevated serum levels of oxidative stress biomarkers in patients with lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010

Beneficial properties of resveratrol in lung epithelial cells: a role for heme oxygenase-1?
Source: Eur Respir J 2005; 26: Suppl. 49, 98s
Year: 2005

Superoxide production by the Nox4 based NAD(P)H oxidase is increased in bronchial biopsies from asthmatic patients. Relationship to lung function
Source: Eur Respir J 2004; 24: Suppl. 48, 683s
Year: 2004

Activation of NRF2 is responsible for the overexpression of peroxiredoxin and sulphiredoxin in human lung cancer
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009

Increased apoptosis in induced sputum cells in stable COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 584s
Year: 2007

Lung expression levels and subcellular localization of heme oxygenase-1 (HO-1) modulate recovery from hyperoxia in neonatal mice
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013


Nitrosoglutathione reductase inhibition in the airway epithelium may contribute to lung cancer risk
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011

Decreased levels of myeloperoxidase in induced sputum of COPD patients after oral glucocorticoids treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 404s
Year: 2002

Expression of MAGE in the induced sputum of lung cancer patients
Source: Eur Respir J 2002; 20: Suppl. 38, 595s
Year: 2002